CAS Lamvac Biotech Co., Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by CAS Lamvac Biotech Co., Ltd.
RECRUITINGPhase 1 / Phase 2NCT03375983
Plasmodium Immunotherapy for Advanced Cancers
The purpose of this study is to evaluate the safety of Plasmodium immunotherapy and preliminarily evaluate the effectiveness of Plasmodium immunotherapy for advanced cancers.The...
Sponsor: CAS Lamvac Biotech Co., Ltd.Enrolling: 201 location
Advanced Cancers
RECRUITINGPhase 1 / Phase 2NCT04165590
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
The purpose of this study is: 1) to evaluate the effectiveness and extended safety of the Plasmodium immunotherapy for the advanced malignant solid tumors. 2) To explore the safe...
Sponsor: CAS Lamvac Biotech Co., Ltd.Enrolling: 601 location
Advanced Malignant Solid Tumor
RECRUITINGPhase 1 / Phase 2NCT03474822
Plasmodium Immunotherapy for Breast and Liver Cancers
The purpose of this study is to evaluate the safety and preliminarily evaluate the effectiveness of Plasmodium immunotherapy for advanced breast cancers and advanced liver...
Sponsor: CAS Lamvac Biotech Co., Ltd.Enrolling: 601 location
Advanced Breast CancerAdvanced Liver Cancer